IRDAI Issues Show Cause Notice To Religare Enterprises Subsidiary
Religare Enterprises Ltd. on Monday said that its subsidiary Care Health Insurance Ltd. has received a show cause notice from the Insurance Regulatory and Development Authority of India.
According to the exchange filing, IRDAI had issued “a letter of advice and a show cause notice” to Care Health Insurance on Dec. 13, 2024. Religare stated that it had received the communication on Monday.
The notice follows the regulator's inspection of the health insurance firm between Aug. 30, 2021, and Sept. 9, 2021, and the submissions made by the Religare subsidiary regarding the inspection.
The letter, which advises caution to Care Health Insurance, has been issued in respect of non-compliance with provisions of various clauses included in the provisions of the regulatory framework of IRDAI. It requires the company to confirm its compliance within 21 days of receiving it.
According to Care Health Insurance, it is in the process of ensuring that the directions in the advisory letter are complied with. The firm added that it will furnish its reply to the show-cause notice along with the supporting documents.
“The company believes that there is no financial or operational impact on the Company or CHIL at this stage,” Religare Enterprises' exchange filing stated.
In the quarter ended Sept. 30, the company had logged a 70% jump in consolidated net profit to Rs 68.49 crore, as compared to Rs 40.35 crore in the year-ago period.
The total revenue in the July-September period increased to Rs 1,971 crore from Rs 1,586 crore in the same quarter of the past fiscal.
Shares of Religare Enterprises closed 0.69% lower at Rs 301.25 apiece on the BSE, compared to a 0.47% decline in the benchmark Sensex.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.